Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
暂无分享,去创建一个
Todd R. Golub | T. Golub | M. Lovett | D. Gilliland | Michael Lovett | G. Barker | D. Gary Gilliland | George F. Barker
[1] M. Lovett,et al. A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization. , 1993, Genomics.
[2] R. H. Knapp,et al. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. , 1985, Mayo Clinic proceedings.
[3] H. Drabkin,et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.
[4] A. Look,et al. Subiocalization of the chromosome 5 breakpoint of the 3;5 translocation in myelodysplastic syndromes and acute myeloid leukemia , 1992 .
[5] J. Rowley,et al. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. , 1981, Blood.
[6] K. Beemon,et al. Nonsense codons within the Rous sarcoma virus gag gene decrease the stability of unspliced viral RNA. , 1991, Molecular and cellular biology.
[7] W. Fantl,et al. Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types , 1993, Molecular and cellular biology.
[8] P. Nowell,et al. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] F. Collins,et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.
[10] P. Seeburg,et al. Tripartite structure of the avian erythroblastosis virus E26 transforming gene , 1983, Nature.
[11] P. Sorensen,et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG , 1994, Nature Genetics.
[12] B. Graves,et al. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. , 1992, Genes & development.
[13] Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. , 1986 .
[14] R. Espinosa,et al. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.
[15] N. Heerema,et al. KRAS2 oncogene overexpression in myelodysplastic syndrome with translocation 5;12. , 1988, Cancer genetics and cytogenetics.
[16] A. Schulz,et al. A novel putative tyrosine kinase receptor with oncogenic potential. , 1991, Oncogene.
[17] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[18] J. Rowley,et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. , 1993, The New England journal of medicine.
[19] B. Birren,et al. Pulsed field gel electrophoresis techniques for separating 1- to 50-kilobase DNA fragments. , 1989, Analytical biochemistry.
[20] E. Reddy,et al. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. , 1993, Oncogene.
[21] M. Mattei,et al. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. , 1989, Oncogene.
[22] Y. Neuman,et al. Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association. , 1991, Cancer genetics and cytogenetics.
[23] I. Pannacciulli,et al. MYELODYSPLASTIC SYNDROME ASSOCIATED WITH INCREASED BONE MARROW FIBROSIS AND TRANSLOCATION (5;12)(q33:p12·3) , 1992, British journal of haematology.
[24] A. Look,et al. Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes , 1988, Cell.
[25] C. T. Davis,et al. Minimal subenhancer requirements for high-level polyomavirus DNA replication: a cell-specific synergy of PEA3 and PEA1 sites , 1990, Molecular and cellular biology.
[26] M. Frohman,et al. Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE. , 1993, Methods in enzymology.
[27] J. Rowley,et al. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. , 1993, Blood.
[28] F. Ruddle,et al. Primary structure of c‐kit: relationship with the CSF‐1/PDGF receptor kinase family–oncogenic activation of v‐kit involves deletion of extracellular domain and C terminus. , 1988, The EMBO journal.
[29] C. Bartram,et al. Molecular genetic aspects of myelodysplastic syndromes. , 1992, Hematology/oncology clinics of North America.
[30] Charles J. Sherr,et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.
[31] D. Birnbaum,et al. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. , 1991, Oncogene.
[32] R. Schulz,et al. Molecular characterization and structural organization of D-elg, an ets proto-oncogene-related gene of Drosophila. , 1992, Oncogene.
[33] D. Pardoll,et al. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations , 1991, Cell.
[34] N. Kamada,et al. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. , 1993, Blood.
[35] A. Ullrich,et al. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors , 1986, Nature.
[36] S. McKnight,et al. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. , 1991, Science.
[37] G. Thomas,et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.
[38] D N Shapiro,et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.
[39] C. Heldin,et al. Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. , 1989, The Journal of biological chemistry.
[40] Leo M. Lee,et al. Characterization of the DNA binding and transcriptional activation domains of the erg protein. , 1993, Oncogene.
[41] M V Olson,et al. Systematic screening of yeast artificial-chromosome libraries by use of the polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[42] R. Warrell,et al. Acute promyelocytic leukemia. , 1993, The New England journal of medicine.
[43] W. Fibbe,et al. t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. , 1993, Cancer genetics and cytogenetics.
[44] A. Kazlauskas,et al. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal , 1993, Cell.
[45] N. Iscove,et al. Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo. , 1994, Oncogene.
[46] C. Carcano,et al. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A , 1993, Molecular and cellular biology.
[47] Y. Hayashi,et al. An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[48] U. Francke,et al. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. , 1993, Blood.
[49] B. Wasylyk,et al. The Ets family of transcription factors. , 1993, European journal of biochemistry.
[50] C. Heldin,et al. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[51] D. Gilliland,et al. Clonal evolution in acute myeloid leukemia [editorial; comment] , 1993 .
[52] J. Weissenbach,et al. A first-generation physical map of the human genome , 1993, Nature.
[53] Michael L. Cleary,et al. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.
[54] W. Rutter,et al. Polymorphic DNA region adjacent to the 5' end of the human insulin gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[55] Susan M. Watanabe,et al. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.
[56] K. Yano,et al. cDNA cloning of transcription factor E4TF1 subunits with Ets and notch motifs , 1993, Molecular and cellular biology.
[57] F. Grant,et al. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[58] G. Rodrigues,et al. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase , 1993, Molecular and cellular biology.
[59] F. Calabi,et al. Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia. , 1993, Blood.
[60] G. Rodrigues,et al. Oncogenic activation of tyrosine kinases. , 1994, Current opinion in genetics & development.
[61] A. Ganser,et al. Clinical course of myelodysplastic syndromes. , 1992, Hematology/oncology clinics of North America.
[62] A. Seth,et al. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. , 1990, Oncogene.
[63] P. Ruff,et al. Abnormalities of chromosome 12p 13 and malignant proliferation of eosinophils: a nonrandom association , 1987, British journal of haematology.